Silexion Therapeutics Reports Positive Preclinical Data Demonstrating SIL204's Reach and Activity in Major Pancreatic Cancer Metastatic Sites Following Systemic Administration

GlobeNewswire
2025.09.11 11:38

新的積極的臨牀前數據表明，在臨牀相關劑量下，藥物成功分佈到肝臟、腹膜和肺部，並且腫瘤負擔顯著減少

Source: GlobeNewswire The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.